A carregar...

Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.

In a randomised, placebo controlled, double blind study inosine pranobex was assessed as a possible second line drug in rheumatoid arthritis. Twenty four patients received inosine pranobex (3 g/day) and 26 patients received placebo for up to 24 weeks. Morning stiffness, articular index, grip strengt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Brzeski, M, Madhok, R, Hunter, J A, Capell, H A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004071/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1693065/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.49.5.293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!